LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$3.43
+0.19 (+5.71%)
Open$3.29
Previous Close$3.24
Day High$3.48
Day Low$3.15
52W High$23.25
52W Low$2.80
Volume—
Avg Volume133.4K
Market Cap5.11M
P/E Ratio—
EPS$-3.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+671.7% upside
Current
$3.43
$3.43
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 928.7K | 665.7K | 9.47M |
| Net Income | -15,656,613 | -10,100,316 | 1.90M |
| Profit Margin | -1,686.0% | -1,601.7% | 20.1% |
| EBITDA | -15,553,850 | -10,591,468 | 3.60M |
| Free Cash Flow | — | — | 1.11M |
| Rev Growth | +39.5% | +39.5% | +1.1% |
| Debt/Equity | — | — | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |